Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 1.22 USD 4.27% Market Closed
Market Cap: 443.3m USD

Relative Value

The Relative Value of one LXRX stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.22 USD, Lexicon Pharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LXRX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
77
vs Industry
65
Median 3Y
84.3
Median 5Y
73.1
Industry
7.8
Forward
9.1
vs History
vs Industry
Median 3Y
-3.1
Median 5Y
-3.4
Industry
24.1
Forward
-7.1
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-3.9
Industry
21.8
vs History
vs Industry
Median 3Y
-3.5
Median 5Y
-3.5
Industry
23.8
vs History
44
vs Industry
62
Median 3Y
2.8
Median 5Y
3.1
Industry
3.3
vs History
69
vs Industry
9
Median 3Y
54
Median 5Y
54
Industry
8
Forward
7.9
vs History
65
vs Industry
6
Median 3Y
57.8
Median 5Y
41.8
Industry
10.3
vs History
vs Industry
33
Median 3Y
-2.1
Median 5Y
-2.7
Industry
6.3
Forward
-6.1
vs History
vs Industry
31
Median 3Y
-2.1
Median 5Y
-2.7
Industry
6.7
Forward
-6.1
vs History
vs Industry
34
Median 3Y
-2.3
Median 5Y
-3.1
Industry
7.9
vs History
vs Industry
30
Median 3Y
-2.3
Median 5Y
-3
Industry
6.3
vs History
73
vs Industry
23
Median 3Y
5.3
Median 5Y
6.7
Industry
5.5

Multiples Across Competitors

LXRX Competitors Multiples
Lexicon Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
443.3m USD 6.3 -6.5 -5.8 -5.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 710 712 -160 222 -194 560.6 -192 340.5
US
Abbvie Inc
NYSE:ABBV
402.8B USD 6.8 171.5 16.6 23.5
US
Amgen Inc
NASDAQ:AMGN
178.3B USD 5 25.5 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
154.2B USD 5.3 19 12.8 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.9B USD 10 31.8 23.4 24.4
US
Epizyme Inc
F:EPE
94.1B EUR 2 089.8 -533.3 -580.7 -565.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.1B USD 5.8 17.9 17.1 19.4
AU
CSL Ltd
ASX:CSL
85.5B AUD 3.7 19 12.8 16
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
53.7B USD 16.7 1 233.4 162.1 196.6
NL
argenx SE
XBRU:ARGX
44.4B EUR 14.5 34.1 58.8 60.4
P/E Multiple
Earnings Growth PEG
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Average P/E: 194
Negative Multiple: -6.5
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 222 N/A N/A
US
Abbvie Inc
NYSE:ABBV
171.5
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
25.5
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
19
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
31.8
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
9%
2
AU
CSL Ltd
ASX:CSL
19
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 233.4
N/A N/A
NL
argenx SE
XBRU:ARGX
34.1
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Average EV/EBITDA: 40.2
Negative Multiple: -5.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 560.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.6
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
11%
1.6
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
162.1
N/A N/A
NL
argenx SE
XBRU:ARGX
58.8
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Average EV/EBIT: 46.4
Negative Multiple: -5.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 340.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.5
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
12%
1.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
13%
1.5
AU
CSL Ltd
ASX:CSL
16
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
196.6
N/A N/A
NL
argenx SE
XBRU:ARGX
60.4
N/A N/A